Paper
0
Tolvaptan in Patients with Autosomal Dominant Polycystic Kidney Disease
Authors
Published
Nov 3, 2012
Show more
Save
Tip0
TipSave
Abstract
The course of autosomal dominant polycystic kidney disease (ADPKD) is often associated with pain, hypertension, and kidney failure. Preclinical studies indicated that vasopressin V2-receptor antagonists inhibit cyst growth and slow the decline of kidney function.
Paper PDF
This paper's license is marked as closed access or non-commercial and cannot be viewed on ResearchHub. Visit the paper's external site.